Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2020 Feb 6

PMID 32021444

Citations 6

Authors

Ting Liu

Yifei Ma

Zhiling Wang

Wenjing Zhang

Xingsheng Yang

Affiliations

Soon will be listed here.

Abstract

Background: Cervical cancer is the second most common female malignancies. But the exact etiology of cervical cancer is still under investigation. Recent observations revealed that the loss expression of Siva 1 was related to several different types of tumors. It could play an indispensable role in both exogenous and endogenous apoptotic signaling pathways. Nevertheless, the relationship between Siva 1 expression and cervical cancer progression has not yet been fully clarified. This study aimed to explore the functional role of Siva1 in cervical cancer.

Materials And Methods: In this present experiment, expression of Siva 1 was detected in 87 cervical cancer, 34 CIN and 20 normal samples by immunohistochemistry. The correlation of Siva 1 expression and overall survival times (OS) was analyzed by Kaplan-Meier analysis. We up-regulated the expression of Siva 1 by plasmid pCMV3-Siva 1 in C33A cells. CCK8, flow cytometry, wound-healing, and transwell assays were performed to examine the influences of Siva 1 expression on cell proliferation, apoptosis, migration and invasion.

Results: The expression of Siva 1 was decreased in cervical cancer tissues compared with CIN and normal tissues. In addition, the Siva 1 immunoreactivity was significantly associated with tumor differentiation. Patients with Siva 1 negative staining exhibited a significantly decreased overall survival. Then, we established stable Siva 1 ectopic expression cells, and we found that elevated expression of Siva 1 promoted apoptosis, inhibited proliferation, and suppressed migration and invasion of cervical cancer cells.

Conclusion: The present study revealed a crucial role of Siva 1 in tumor progression and it may be a valuable prognostic indicator of cervical cancer.

Citing Articles

SIVA-1 interaction with PCBP1 serves as a predictive biomarker for cisplatin sensitivity in gastric cancer and its inhibitory effect on tumor growth .

Kong F, Shi Z, Huang Y, Chen H, Deng Q, Wu K J Cancer. 2024; 15(13):4301-4312.

PMID: 38947376 PMC: 11212092. DOI: 10.7150/jca.92963.

Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.

Vermehren-Schmaedick A, Peto M, Wagoner W, Chiotti K, Ramsey E, Wang X PLoS One. 2024; 19(5):e0302856.

PMID: 38722955 PMC: 11081324. DOI: 10.1371/journal.pone.0302856.

Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.

Shen J, Wang Q, Mao Y, Gao W, Duan S MedComm (2020). 2023; 4(3):e288.

PMID: 37256211 PMC: 10225743. DOI: 10.1002/mco2.288.

FAIM-L - SIVA-1: Two Modulators of XIAP in Non-Apoptotic Caspase Function.

Coccia E, Sole M, Comella J Front Cell Dev Biol. 2022; 9:826037.

PMID: 35083225 PMC: 8784879. DOI: 10.3389/fcell.2021.826037.

A Personalized Genomics Approach of the Prostate Cancer.

Iacobas S, Iacobas D Cells. 2021; 10(7).

PMID: 34209090 PMC: 8305988. DOI: 10.3390/cells10071644.

References

Gudi R, Barkinge J, Hawkins S, Chu F, Manicassamy S, Sun Z . Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD). Oncogene. 2006; 25(24):3458-62. DOI: 10.1038/sj.onc.1209381. View

Seseke F, Thelen P, Ringert R . Characterization of an animal model of spontaneous congenital unilateral obstructive uropathy by cDNA microarray analysis. Eur Urol. 2004; 45(3):374-81. DOI: 10.1016/j.eururo.2003.10.010. View

Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti P . Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2. Cancer Res. 2005; 65(12):5301-9. DOI: 10.1158/0008-5472.CAN-04-3270. View

Chu F, Borthakur A, Sun X, Barkinge J, Gudi R, Hawkins S . The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis. 2004; 9(1):83-95. DOI: 10.1023/B:APPT.0000012125.01799.4c. View

Fortin A, MacLaurin J, Arbour N, Cregan S, Kushwaha N, Callaghan S . The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem. 2004; 279(27):28706-14. DOI: 10.1074/jbc.M400376200. View

Spinicelli S, Nocentini G, Ronchetti S, Krausz L, Bianchini R, Riccardi C . GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. Cell Death Differ. 2002; 9(12):1382-4. DOI: 10.1038/sj.cdd.4401140. View

Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T . Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol. 2001; 74(9):4284-90. PMC: 111945. DOI: 10.1128/jvi.74.9.4284-4290.2000. View

Chen G, Xue Q, Li J, Gao T, Sun Q, Bai G . Anticancer activity of recombinant Siva1 protein in human nasopharyngeal carcinoma cell line CNE-2. Cancer Biomark. 2015; 15(6):833-41. DOI: 10.3233/CBM-150527. View

Resch U, Schichl Y, Winsauer G, Gudi R, Prasad K, de Martin R . Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis. J Cell Sci. 2009; 122(Pt 15):2651-61. DOI: 10.1242/jcs.049940. View

10.

Machado-Neto J, Lazarini M, Favaro P, Campos P, Scopim-Ribeiro R, Franchi Junior G . ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. Biochim Biophys Acta. 2014; 1853(3):583-93. DOI: 10.1016/j.bbamcr.2014.12.012. View

11.

Gravestein L, Blom B, Nolten L, de Vries E, Van Der Horst G, Ossendorp F . Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family. Eur J Immunol. 1993; 23(4):943-50. DOI: 10.1002/eji.1830230427. View

12.

Py B, Slomianny C, Auberger P, Petit P, Benichou S . Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway. J Immunol. 2004; 172(7):4008-17. DOI: 10.4049/jimmunol.172.7.4008. View

13.

Xue L, Chu F, Cheng Y, Sun X, Borthakur A, Ramarao M . Siva-1 binds to and inhibits BCL-X(L)-mediated protection against UV radiation-induced apoptosis. Proc Natl Acad Sci U S A. 2002; 99(10):6925-30. PMC: 124505. DOI: 10.1073/pnas.102182299. View

14.

Zhang Y, Yu L, Zhu W, Wang S, Wang D, Yang Y . Preliminary research on the expression, purification and function of the apoptotic fusion protein, Sival. Asian Pac J Cancer Prev. 2014; 15(20):8685-8. DOI: 10.7314/apjcp.2014.15.20.8685. View

15.

Prasad K, Ao Z, Yoon Y, Wu M, Rizk M, Jacquot S . CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci U S A. 1997; 94(12):6346-51. PMC: 21052. DOI: 10.1073/pnas.94.12.6346. View

16.

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

17.

Jacobs S, Basak S, Murray J, Pathak N, Attardi L . Siva is an apoptosis-selective p53 target gene important for neuronal cell death. Cell Death Differ. 2007; 14(7):1374-85. DOI: 10.1038/sj.cdd.4402128. View

18.

Mei Y, Wu M . Multifaceted functions of Siva-1: more than an Indian God of Destruction. Protein Cell. 2012; 3(2):117-22. PMC: 4875415. DOI: 10.1007/s13238-012-2018-5. View

19.

Cao C, Ren X, Kharbanda S, Koleske A, Koleske A, Prasad K . The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress. J Biol Chem. 2001; 276(15):11465-8. DOI: 10.1074/jbc.C100050200. View

20.

Tang J, Yang Z, Wang Z, Li Z, Li H, Yin J . Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer. World J Surg Oncol. 2017; 15(1):173. PMC: 5604510. DOI: 10.1186/s12957-017-1221-5. View